NO: a key player in microbiome dynamics and cancer pathogenesis
Seyedeh Kimia Jasemi(Kermanshah University of Medical Sciences), Zhila Izadi(Razi University), Mohammed Namiq Amin(Kermanshah University of Medical Sciences), Mehregan Babamohamadi(University of Tabriz), Roshanak Amirian(Kermanshah University of Medical Sciences), Hossein Faridafshar(Shahed University), Marjan Falahati(Kermanshah University of Medical Sciences)
Cited by 3
Related Papers
Anti-CTLA-4 nanobody as a promising approach in cancer immunotherapy
|Cell Death and Disease|2024|83
Recent findings on the role of wild-type and mutant p53 in cancer development and therapy
|Frontiers in Molecular Biosciences|2022|31
Types of RNA therapeutics
|Progress in molecular biology and translational science|2024|14
Phytostilbenes in lymphoma: Focuses on the mechanistic and clinical prospects of resveratrol, pterostilbene, piceatannol, and pinosylvin
|Leukemia Research|2024|14
Recent advances in targeting LRRK2 for Parkinson’s disease treatment
|Journal of Translational Medicine|2025|14